Cas:54810-82-1 2,6-dimethyl-4-phenylaniline manufacturer & supplier

Chemical Name:2,6-dimethyl-4-phenylaniline

CAS.NO:54810-82-1

Synonyms:4-phenyl-2,6-dimethylaniline;3,5-dimethyl-4-aminobiphenyl;4-Amino-3.5-dimethyl-biphenyl;3,5-Dimethyl-biphenyl-4-ylamin;3,5-dimethyl-biphenyl-4-ylamine

Molecular Formula:C₁₄H₁₅N

Molecular Weight:197.27600

HS Code:2921499090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:316.2ºC at 760 mmHg

Density:1.04g/cm3

Index of Refraction:1.598

PSA:26.02000

Exact Mass:197.12000

LogP:4.13380

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-phenyl-2,6-dimethylaniline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3,5-dimethyl-biphenyl-4-ylamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,5-dimethyl-biphenyl-4-ylamine Use and application,3,5-dimethyl-biphenyl-4-ylamine technical grade,usp/ep/jp grade.

Related News: Bulk drug substances mainly include vitamins, antibiotics, hormones, antipyretics and analgesics, among which vitamin C, erythromycin thiocyanate, penicillin, azithromycin, and semi-synthetic cephalosporins are the most concentrated products in the industry in terms of production and overcapacity. 2,6-dimethyl-4-phenylaniline manufacturer In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of ��predictable�� clinical value for life-threatening diseases for which effective treatment is not immediately available. 2,6-dimethyl-4-phenylaniline supplier Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries. 2,6-dimethyl-4-phenylaniline vendor In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of ��predictable�� clinical value for life-threatening diseases for which effective treatment is not immediately available. 2,6-dimethyl-4-phenylaniline factory But it has been barred from that body as Beijing has increased pressure on Taiwan under President Tsai Ing-wen, who is skeptical about closer ties with China.